NJ A 872
in committeeProhibits discrimination against individuals who have not received COVID-19 vaccine.
New Jersey · 222 · lower
Quick answers
Did NJ A 872 pass?
Not yet. NJ A 872 is in committee as of 2026-01-13 and has not come to a final vote. Latest recorded action (2026-01-13): Introduced, Referred to Assembly Community Development and Women's Affairs Committee
What is NJ A 872 about?
NJ A 872 is a bill in the 222 titled “Prohibits discrimination against individuals who have not received COVID-19 vaccine.”.
Who sponsors NJ A 872?
Scharfenberger, Gerry, McGuckin, Gregory P., Flynn, Victoria A. are the primary sponsors of NJ A 872, joined by 6 cosponsors.
- Introduced
- 2026-01-13
- Latest action
- 2026-01-13 — Introduced, Referred to Assembly Community Development and Women's Affairs Committee
- Bill type
- bill
- Last updated
- —
Sponsors
- Scharfenberger, Gerryprimary
- McGuckin, Gregory P.primary
- Flynn, Victoria A.primary
- Inganamort, Michaelcosponsor
- Fantasia, Dawncosponsor
- Azzariti Jr., John V., M.D.cosponsor
- Kanitra, Paulcosponsor
- Webber, Jaycosponsor
- Auth, Robertcosponsor
Committees
Not provided by source.
Action timeline
2026-01-13
Introduced, Referred to Assembly Community Development and Women's Affairs Committee
introduction,referral-committee
Versions
- IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
- Companion bill: S 69
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:27:43.923511Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NJ&identifier=A 872. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.